BACKGROUND: Apolipoprotein E (APOE) ε4 is related to faster decline in episodic memory in Whites, but the relation is unknown in Blacks. The purpose of this study was to determine whether ε4 has a selective effect on decline in episodic memory in Blacks. METHODS: Data are from two cohort studies with similar design. The sample consisted of 1,211 participants [28.4% Blacks, mean age = 78.6 years (SD = 7.4), education = 14.7 years (SD = 3.1)] without dementia at baseline, who underwent annual clinical evaluations for up to 6 years. Summary measures of 5 cognitive abilities were derived from 18 neuropsychological tests. RESULTS: In mixed models that controlled for age, sex, education, and race, possession of ε4 (present in 32.9% of Blacks and 21.0% of Whites, p < 0.001) was related to faster decline in episodic memory and 4 other cognitive abilities (all p values <0.01). In separate models that examined the interaction of race and ε4 on decline, there was no significant difference between Blacks and Whites in the effect of ε4 on decline in episodic memory, perceptual speed, or visuospatial ability. By contrast, the effect of ε4 differed for semantic memory and working memory. Results were similar after adjusting for vascular conditions. CONCLUSIONS: The results suggest that APOE ε4 is related to a faster rate of decline in episodic memory in Blacks similar to Whites. In addition, there were racial differences in the effect of ε4 in other cognitive abilities such that the ε4 allele was related to faster decline in semantic memory and working memory for Whites but not for Blacks.
BACKGROUND:Apolipoprotein E (APOE) ε4 is related to faster decline in episodic memory in Whites, but the relation is unknown in Blacks. The purpose of this study was to determine whether ε4 has a selective effect on decline in episodic memory in Blacks. METHODS: Data are from two cohort studies with similar design. The sample consisted of 1,211 participants [28.4% Blacks, mean age = 78.6 years (SD = 7.4), education = 14.7 years (SD = 3.1)] without dementia at baseline, who underwent annual clinical evaluations for up to 6 years. Summary measures of 5 cognitive abilities were derived from 18 neuropsychological tests. RESULTS: In mixed models that controlled for age, sex, education, and race, possession of ε4 (present in 32.9% of Blacks and 21.0% of Whites, p < 0.001) was related to faster decline in episodic memory and 4 other cognitive abilities (all p values <0.01). In separate models that examined the interaction of race and ε4 on decline, there was no significant difference between Blacks and Whites in the effect of ε4 on decline in episodic memory, perceptual speed, or visuospatial ability. By contrast, the effect of ε4 differed for semantic memory and working memory. Results were similar after adjusting for vascular conditions. CONCLUSIONS: The results suggest that APOE ε4 is related to a faster rate of decline in episodic memory in Blacks similar to Whites. In addition, there were racial differences in the effect of ε4 in other cognitive abilities such that the ε4 allele was related to faster decline in semantic memory and working memory for Whites but not for Blacks.
Authors: R S Wilson; P A Scherr; J L Bienias; C F Mendes de Leon; S A Everson-Rose; D A Bennett; D A Evans Journal: Exp Aging Res Date: 2005 Oct-Dec Impact factor: 1.645
Authors: A Sahota; M Yang; S Gao; S L Hui; O Baiyewu; O Gureje; S Oluwole; A Ogunniyi; K S Hall; H C Hendrie Journal: Ann Neurol Date: 1997-10 Impact factor: 10.422
Authors: P A Boyle; R S Wilson; N T Aggarwal; Z Arvanitakis; J Kelly; J L Bienias; D A Bennett Journal: Neurology Date: 2005-12-27 Impact factor: 9.910
Authors: M X Tang; Y Stern; K Marder; K Bell; B Gurland; R Lantigua; H Andrews; L Feng; B Tycko; R Mayeux Journal: JAMA Date: 1998-03-11 Impact factor: 56.272
Authors: Jill R Murrell; Brandon Price; Kathleen A Lane; Olusegun Baiyewu; Oye Gureje; Adesola Ogunniyi; Frederick W Unverzagt; Valerie Smith-Gamble; Sujuan Gao; Hugh C Hendrie; Kathleen S Hall Journal: Arch Neurol Date: 2006-03
Authors: Robert S Wilson; Lisa L Barnes; Kristin R Krueger; George Hoganson; Julia L Bienias; David A Bennett Journal: J Int Neuropsychol Soc Date: 2005-07 Impact factor: 2.892
Authors: L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn Journal: JAMA Date: 1997 Oct 22-29 Impact factor: 56.272
Authors: Jessica R Marden; Elizabeth R Mayeda; Stefan Walter; Alexandre Vivot; Eric J Tchetgen Tchetgen; Ichiro Kawachi; M Maria Glymour Journal: Alzheimer Dis Assoc Disord Date: 2016 Jul-Sep Impact factor: 2.703
Authors: Linda Chang; Caroline Jiang; Eric Cunningham; Steven Buchthal; Vanessa Douet; Marilou Andres; Thomas Ernst Journal: Neurology Date: 2014-05-21 Impact factor: 9.910
Authors: Yih-Ing Hser; Linda Chang; Gene-Jack Wang; Ming D Li; Richard Rawson; Steve Shoptaw; Jacques Normand; Betty Tai Journal: J Food Drug Anal Date: 2013-12-01 Impact factor: 6.079
Authors: Owen A Williams; Yang An; Nicole M Armstrong; Andrea T Shafer; Jessica Helphrey; Melissa Kitner-Triolo; Luigi Ferrucci; Susan M Resnick Journal: Alzheimers Dement Date: 2019-09-24 Impact factor: 21.566
Authors: Kumar B Rajan; Lisa L Barnes; Robert S Wilson; Jennifer Weuve; Elizabeth A McAninch; Denis A Evans Journal: J Am Geriatr Soc Date: 2018-12-24 Impact factor: 5.562
Authors: Jennifer Weuve; Lisa L Barnes; Carlos F Mendes de Leon; Kumar B Rajan; Todd Beck; Neelum T Aggarwal; Liesi E Hebert; David A Bennett; Robert S Wilson; Denis A Evans Journal: Epidemiology Date: 2018-01 Impact factor: 4.822
Authors: Sukriti Nag; Lisa L Barnes; Lei Yu; Robert S Wilson; David A Bennett; Julie A Schneider Journal: Neurology Date: 2020-08-05 Impact factor: 9.910